2024年10月18日,医疗科技股医脉通(02192)盘中股价大涨6.37%,报收于8.97港元。这一走势引发了市场的广泛关注。
分析人士表示,推动医脉通股价上涨的主要原因在于公司基本面表现向好,吸引了大量资金流入。公司最新财报显示,医脉通实现营业收入2.67亿港元,净利润达1.61亿港元,每股收益0.22港元,盈利能力持续增长。同时,所有参与评级的4家机构均给予该股"买入"评级,认为公司发展前景广阔。
另一方面,医疗健康产业近年来成为市场追捧的热门投资领域,受此因素影响,医脉通作为该行业龙头股之一也获得了较多关注和资金青睐。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.